Evidence map›Paper›PMID 38102071›Full record

Trial reportEuropean journal of preventive cardiology2024

Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome.

Xavier Rossello, Raúl Ramallal, Dora Romaguera, Ángel M Alonso-Gómez, Alvaro Alonso, Lucas Tojal-Sierra, Carlos Fernández-Palomeque, Miguel Ángel Martínez-González, María Garrido-Uriarte, Luis López and 6 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of preventive cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Glycemic status and left atrial structure and function in adults with metabolic syndrome and overweight-obesity.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Xavier RosselloHospital Universitari Son Espases, Health Research Institute of the Balearic Islands (IdISBa), Carretera de Valldemossa, 79, 07120 Palma, Spain.
Raúl RamallalDepartment of Cardiology, University Hospital of Navarra, Servicio Navarro de Salud Osasunbidea, IDISNA, Pamplona, Spain.
Dora RomagueraHospital Universitari Son Espases, Health Research Institute of the Balearic Islands (IdISBa), Carretera de Valldemossa, 79, 07120 Palma, Spain.ORCID 0000-0002-5762-8558
Ángel M Alonso-GómezCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0002-2225-8323
Lucas Tojal-SierraCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Carlos Fernández-PalomequeHospital Universitari Son Espases, Health Research Institute of the Balearic Islands (IdISBa), Carretera de Valldemossa, 79, 07120 Palma, Spain.
Miguel Ángel Martínez-GonzálezCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.ORCID 0000-0002-5104-1262
María Garrido-UriarteBioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Luis LópezCardiology Service, Hospital de Manacor, Manacor, Spain.
Agnes DíazCardiology Service, Clinica Universidad de Navarra, Pamplona, Spain.
Olatz Zaldua-IrastorzaBioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Amit J ShahDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Jordi Salas-SalvadóCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Montserrat FitóCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Estefania ToledoCIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), C/Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Instituto de Salud Carlos III · ESUniversity of the Basque Country · ESEmory University · USHealth Research Institute of the Balearic Islands · ESClinica Universidad de Navarra · ESFundación Hospital Manacor · ESHarvard University · USServicio Navarro de Salud · ES

Funding

Effect of an Intensive Lifestyle Intervention on the Atrial Fibrillation SubstrateR01HL137338 · NHLBI · EMORY UNIVERSITY · PI ALONSO, ALVARO · 2018 to 2021
$2.8M
Mentoring in patient-oriented atrial fibrillation and cardiovascular researchK24HL148521 · NHLBI · EMORY UNIVERSITY · PI ALONSO, ALVARO · 2019 to 2023
$593k
European Research Council 340918NHLBI NIH HHSNHLBI NIH HHS K24 HL148521NHLBI NIH HHS R01 HL137338NIH HHS R01HL137338 and K24HL148521
6 · The paper itself

Abstract

aimsTo evaluate the effect of an intensive lifestyle intervention (ILI) on the structural and functional cardiac substrate of atrial fibrillation (AF) in overweight or obese people with metabolic syndrome (Mets). METHODS AND

resultsParticipants of the PREvención con DIeta MEDiterranea-Plus trial (n = 6874) were randomized 1:1 to an ILI programme based on an energy-reduced Mediterranean diet, increased physical activity, and cognitive-behavioural weight management or to a control intervention of low-intensity dietary advice. A core echocardiography lab evaluated left atrial (LA) strain, function, and volumes in 534 participants at baseline, 3-year, and 5-year follow-ups. Mixed models were used to evaluate the effect of the ILI on LA structure and function. In the subsample, the baseline mean age was 65 years [standard deviation (SD) 5 years], and 40% of the participants were women. The mean weight change after 5 years was -3.9 kg (SD 5.3 kg) in the ILI group and -0.3 kg (SD 5.1 kg) in the control group. Over the 5-year period, both groups experienced a worsening of LA structure and function, with increases in LA volumes and stiffness index and decreases in LA longitudinal strain, LA function index, and LA emptying fraction over time. Changes in the ILI and control groups were not significantly different for any of the primary outcomes {LA emptying fraction: -0.95% [95% confidence interval (CI) -0.93, -0.98] in the control group, -0.97% [95% CI -0.94, -1.00] in the ILI group, Pbetween groups = 0.80; LA longitudinal strain: 0.82% [95% CI 0.79, 0.85] in the control group, 0.85% [95% CI 0.82, 0.89] in the ILI group, Pbetween groups = 0.24} or any of the secondary outcomes.

conclusionIn overweight or obese people with Mets, an ILI had no impact on the underlying structural and functional LA substrate measurements associated with AF risk.

Indexed as

Atrial FibrillationMetabolic SyndromeAgedExerciseFemaleHumansLife StyleMaleObesityOverweightAtrial fibrillationIntensive lifestyle interventionMediterranean dietMetabolic syndromeObesity

Identifiers

PMID38102071
PMCPMC10972629
OpenAlexW4389804789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.